Astellas Pharma Inc: Hot Flashes trials

The registry lists 17 Hot Flashes studies with Astellas Pharma Inc as lead sponsor. 2 are open to participants now and 5 have results posted.

Phase 2 4Phase 3 10No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Confirm if Fezolinetant Helps to Reduce Hot Flashes in Indian Women Going Through MenopauseNot yet recruitingNCT07829653Phase 3
• A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical PracticeRecruitingNCT07602530
• Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot FlashesCompletedNCT05419908Phase 2Results posted
• A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through MenopauseCompletedNCT04003389Phase 3Results posted
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through MenopauseCompletedNCT04003155Phase 3Results posted
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2CompletedNCT04003142Phase 3Results posted
• A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)CompletedNCT03192176Phase 2Results posted
• A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During MenopauseCompletedNCT07455812
• A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through MenopauseCompletedNCT06812754Phase 2
• A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone TherapyActive, not recruitingNCT06440967Phase 3
• A Study to Assess Long-term Safety of Fezolinetant Given to Japanese Women Going Through MenopauseCompletedNCT06206421Phase 3
• A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Japanese Women Going Through MenopauseCompletedNCT06206408Phase 3
• A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night SweatsCompletedNCT06049797
• A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through MenopauseCompletedNCT05034042Phase 2
• A Study of Fezolinetant to Treat Hot Flashes in Women Going Through MenopauseCompletedNCT05033886Phase 3
• A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With MenopauseCompletedNCT04451226Phase 3
• A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women in Asia Going Through MenopauseCompletedNCT04234204Phase 3